HDDO-1801 Intervention Trial

NCT04097951 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Disease

Interventions

DRUG: Combinations

Sponsor

Hyundai Pharmaceutical Co., LTD.